Publicação:
Metabolic profile and safety of piperlongumine

Carregando...
Imagem de Miniatura

Data

2016-09-29

Orientador

Coorientador

Pós-graduação

Curso de graduação

Título da Revista

ISSN da Revista

Título de Volume

Editor

Nature Publishing Group

Tipo

Artigo

Direito de acesso

Acesso abertoAcesso Aberto

Resumo

Piperlongumine (PPL), a natural plant product, has been extensively studied in cancer treatment going up on clinical trials. Since the first report related to its use on cancer research (in 2011) around 80 papers have been published in less than 10 years, but a gap still remaining. There are no metabolism studies of PPL in human organism. For the lack of a better view, here, the CYP450 in vitro oxidation of PPL was described for the first time. In addition, the enzymatic kinetic data, the predicted in vivo parameters, the produced metabolites, the phenotyping study and possible piperlongumine-drug interactions in vivo is presented.

Descrição

Palavras-chave

Idioma

Inglês

Como citar

Scientific Reports. London: Nature Publishing Group, v. 6, 9 p., 2016.

Itens relacionados

Unidades

Departamentos

Cursos de graduação

Programas de pós-graduação